Professor Stephen Riordan

Gastroenterology and the Liver

MBBS (Hons), MD (UNSW), FRACP, FRCP (London)

Scientific Publications

33. Luminal anti-gliadin antibodies in small intestinal bacterial overgrowth. American Journal of Gastroenterology 1997; 92: 1335-1338.
34. Treatment of hepatic encephalopathy. New England Journal of Medicine 1997; 337: 473-479.
35. Bioartificial liver support: developments in hepatocyte culture and bioreactor design. British Medical Bulletin 1997; 53: 1-15.
36. Experience in design of controlled clinical trials in acute liver failure. In: Crepaldi G, Demetriou AA, Muraca M (Eds). Bioartificial Liver Support Systems: The Critical Issues. CIC Edizioni Internationali, Rome, 1997: 104-115.
37. The prevalence of liver damage in human small intestinal bacterial overgrowth. Journal of Hepatology 1997; 26 (Suppl 1): 177.
38. Hepatitis C virus-specific T helper cell responses in recurrent hepatitis C after liver transplantation. Journal of Hepatology 1997; 26 (Suppl 1): 145.
39. Hepatotoxicity of designer drugs. Proceedings of the Royal College of Pathologists Scientific Conference, London, 1998.
40. Liver disease due to illicit substance use. Addiction Biology 1998; 3: 47-53.
41. Liver damage in human small intestinal bacterial overgrowth. American Journal of Gastroenterology 1998; 93: 234-237.
42. Preoperative investigation and indication for operation in hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Surgery 1998; 5: 1-6.
43. Interleukin-6 and small intestinal luminal immunoglobulins. Digestive Diseases and Sciences 1998; 43: 442-445.
44. A randomised study comparing ribavirin and interferon-alpha monotherapy for hepatitis C recurrence after liver transplantation. Hepatology 1998; 27: 1403-1407.
45. Evolving therapies for chronic viral hepatitis. Gastroenterology Today 1998; 2: 29-35.
46. Metabolic activity and clinical efficacy of animal and human hepatocytes in bioartificial support systems for acute liver failure. International Journal of Artificial Organs 1998; 21: 312-318.
47. Tumour ablation and hepatic decompensation rates with multi-agent chemoembolisation of hepatocellular carcinoma. Quarterly Journal of Medicine 1998; 91: 821-828.
48. The bioartificial liver. In: Advances in Therapeutic Hepatology - A World View. International Association for the Study of the Liver Postgraduate Syllabus, Chicago, 1998: 155-163.